• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过在调节性磷酸化位点将丝氨酸14替换为酸性残基来实现肌肉磷酸化酶的部分激活。

Partial activation of muscle phosphorylase by replacement of serine 14 with acidic residues at the site of regulatory phosphorylation.

作者信息

Buchbinder J L, Luong C B, Browner M F, Fletterick R J

机构信息

Department of Biochemistry, University of California, San Francisco, 94143-0448, USA.

出版信息

Biochemistry. 1997 Jul 1;36(26):8039-44. doi: 10.1021/bi9704820.

DOI:10.1021/bi9704820
PMID:9201951
Abstract

Phosphorylation of glycogen phosphorylase at residue Ser14 triggers a conformational transition that activates the enzyme. The N-terminus of the protein, in response to phosphorylation, folds into a 310 helix and moves from its location near a cluster of acidic residues on the protein surface to a site at the dimer interface where a pair of arginine residues form charged hydrogen bonds with the phosphoserine. Site-directed mutagenesis was used to replace Ser14 with Asp and Glu residues, analogs of the phosphoserine, that might be expected to participate in ionic interactions with the arginine side chains at the dimer interface. Kinetic analysis of the mutants indicates that substitution of an acidic residue in place of Ser14 at the site of regulatory phosphorylation partially activates the enzyme. The S14D mutant shows a 1.6-fold increase in Vmax, a 10-fold decrease in the apparent dissociation constant for AMP, and a 3-fold decrease in the S0.5 for glucose 1-phosphate. The S14E mutant behaves similarly, showing a 2.2-fold increase in Vmax, a 6-fold decrease in the apparent dissociation constant for AMP, and a 2-fold decrease in the S0.5 for glucose 1-phosphate. The ability of the mutations to enhance binding of AMP and glucose 1-phosphate and to raise catalytic activity suggests that the introduction of a carboxylate side chain at position 14 promotes docking of the N-terminus at the subunit interface and concomitant stabilization of the activated conformation of the enzyme. Like the native enzyme, both mutants show significant activity only in the presence of the activator, AMP. Full activation, analogous to that provided by covalent phosphorylation of the enzyme, likely is not achieved because of differences in the charge and the geometry of ionic interactions at the phosphorylation site.

摘要

糖原磷酸化酶在丝氨酸14位点的磷酸化引发了构象转变,从而激活该酶。响应磷酸化,蛋白质的N端折叠成一个310螺旋,并从其在蛋白质表面靠近一簇酸性残基的位置移动到二聚体界面处的一个位点,在该位点一对精氨酸残基与磷酸丝氨酸形成带电氢键。定点诱变用于将丝氨酸14替换为天冬氨酸和谷氨酸残基,它们是磷酸丝氨酸的类似物,预计可参与与二聚体界面处精氨酸侧链的离子相互作用。对突变体的动力学分析表明,在调节性磷酸化位点用酸性残基取代丝氨酸14可部分激活该酶。S14D突变体的Vmax增加了1.6倍,AMP的表观解离常数降低了10倍,1-磷酸葡萄糖的S0.5降低了3倍。S14E突变体表现类似,Vmax增加了2.2倍,AMP的表观解离常数降低了6倍,1-磷酸葡萄糖的S0.5降低了两倍。这些突变增强AMP和1-磷酸葡萄糖结合以及提高催化活性的能力表明,在14位引入羧酸盐侧链促进了N端在亚基界面的对接以及酶激活构象的伴随稳定。与天然酶一样,这两个突变体仅在激活剂AMP存在时才表现出显著活性。由于磷酸化位点离子相互作用的电荷和几何形状不同,可能无法实现类似于酶共价磷酸化所提供的完全激活。

相似文献

1
Partial activation of muscle phosphorylase by replacement of serine 14 with acidic residues at the site of regulatory phosphorylation.通过在调节性磷酸化位点将丝氨酸14替换为酸性残基来实现肌肉磷酸化酶的部分激活。
Biochemistry. 1997 Jul 1;36(26):8039-44. doi: 10.1021/bi9704820.
2
Crystallographic binding studies on the allosteric inhibitor glucose-6-phosphate to T state glycogen phosphorylase b.变构抑制剂6-磷酸葡萄糖与T态糖原磷酸化酶b的晶体学结合研究。
J Mol Biol. 1993 Jul 5;232(1):253-67. doi: 10.1006/jmbi.1993.1380.
3
Role of the active site gate of glycogen phosphorylase in allosteric inhibition and substrate binding.糖原磷酸化酶活性位点门在变构抑制和底物结合中的作用。
J Biol Chem. 1996 Sep 13;271(37):22305-9. doi: 10.1074/jbc.271.37.22305.
4
Allosteric inhibition of glycogen phosphorylase a by the potential antidiabetic drug 3-isopropyl 4-(2-chlorophenyl)-1,4-dihydro-1-ethyl-2-methyl-pyridine-3,5,6-tricarbo xylate.潜在抗糖尿病药物3-异丙基-4-(2-氯苯基)-1,4-二氢-1-乙基-2-甲基吡啶-3,5,6-三羧酸酯对糖原磷酸化酶a的变构抑制作用
Protein Sci. 1999 Oct;8(10):1930-45. doi: 10.1110/ps.8.10.1930.
5
Evolution of allosteric control in glycogen phosphorylase.糖原磷酸化酶变构调控的进化
J Mol Biol. 1993 Dec 5;234(3):700-21. doi: 10.1006/jmbi.1993.1621.
6
Structural mechanism for glycogen phosphorylase control by phosphorylation and AMP.磷酸化和AMP对糖原磷酸化酶的调控的结构机制
J Mol Biol. 1991 Mar 5;218(1):233-60. doi: 10.1016/0022-2836(91)90887-c.
7
Investigation of a catalytic zinc binding site in Escherichia coli L-threonine dehydrogenase by site-directed mutagenesis of cysteine-38.通过对半胱氨酸-38进行定点诱变研究大肠杆菌L-苏氨酸脱氢酶中的催化锌结合位点。
Arch Biochem Biophys. 1998 Oct 15;358(2):211-21. doi: 10.1006/abbi.1998.0845.
8
[Glycogen phosphorylase of skeletal muscles].[骨骼肌糖原磷酸化酶]
Biokhimiia. 1986 Dec;51(12):1974-92.
9
Electrostatic activation of rat phenylalanine hydroxylase.大鼠苯丙氨酸羟化酶的静电激活
Biochem Biophys Res Commun. 1994 Jan 14;198(1):174-80. doi: 10.1006/bbrc.1994.1025.
10
The allosteric transition of glycogen phosphorylase.糖原磷酸化酶的别构转变
Nature. 1989 Aug 24;340(6235):609-16. doi: 10.1038/340609a0.

引用本文的文献

1
McArdle Disease: New Insights into Its Underlying Molecular Mechanisms.麦卡德尔病:对其潜在分子机制的新认识。
Int J Mol Sci. 2019 Nov 25;20(23):5919. doi: 10.3390/ijms20235919.
2
20-HETE induces hyperglycemia through the cAMP/PKA-PhK-GP pathway.20-羟基二十碳四烯酸通过环磷酸腺苷/蛋白激酶A-磷酸化酶激酶-糖原磷酸化酶途径诱导高血糖。
Mol Endocrinol. 2012 Nov;26(11):1907-16. doi: 10.1210/me.2012-1139. Epub 2012 Aug 23.
3
Acetylation negatively regulates glycogen phosphorylase by recruiting protein phosphatase 1.乙酰化通过招募蛋白磷酸酶 1 负调控糖原磷酸化酶。
Cell Metab. 2012 Jan 4;15(1):75-87. doi: 10.1016/j.cmet.2011.12.005.
4
The N-terminus of glycogen phosphorylase b is not required for activation by adenosine 5'-monophosphate.糖原磷酸化酶 b 的 N 端对于 AMP 的激活并非必需。
Biochemistry. 2010 Jun 15;49(23):4760-5. doi: 10.1021/bi9020555.
5
A mechanism for the direct regulation of T-type calcium channels by Ca2+/calmodulin-dependent kinase II.一种由Ca2+/钙调蛋白依赖性激酶II直接调节T型钙通道的机制。
J Neurosci. 2003 Nov 5;23(31):10116-21. doi: 10.1523/JNEUROSCI.23-31-10116.2003.